Dr. Martens annual stock-based compensation
2021
2022
2023
2024
2025
2026
Dr. Martens Stock-Based Compensation Growth & History (DOCS)
Dr. Martens's stock-based compensation was £5.2M for fiscal 2026.
View full Dr. Martens company overviewDr. Martens annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-29 | £5.2M | −£2.0M | −27.78% |
| 2025 | 2025-03-30 | £7.2M | £3.2M | +80.00% |
| 2024 | 2024-03-31 | £4.0M | £3.5M | +700.00% |
| 2023 | 2023-03-31 | £500,000 | −£4.7M | −90.38% |
| 2022 | 2022-03-31 | £5.2M | −£6.3M | −54.78% |
| 2021 | 2021-03-31 | £11.5M | — | — |
Dr. Martens stock-based compensation trends
Over the last five fiscal years, Dr. Martens's stock-based compensation decreased from £11.5M to £5.2M, a change of −£6.3M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
reported stock-based compensation
TickerStat standardizes share-based compensation reported in company official filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dr. Martens source filings ↗